Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

New Dymax MD(R) 1040-M Autoclave Resistant Adhesive for Medical Instruments and Assembly

SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Dymax Corporation, leading manufacturer of rapid curing materials and equipment, unveils its newest product, 1040-M, as part of its MD® line of adhesives for medical device assembly applications. Designed to be autoclave resistant for more than 100 cycles...

2021-10-13 10:00 1699

SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseases

SOPHiA Clinical Exome Solution v3 offers a streamlined end-to-end workflow to facilitate the assessment of challenging Mendelian disorders BOSTON and LAUSANNE, Switzerland, Oct. 13, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing...

2021-10-13 05:16 1597

DarwinHealth Announces Scientific Collaboration with Prelude Therapeutics to Develop Novel Biomarkers for Multiple Oncology Candidates

NEW YORK, Oct. 12, 2021 /PRNewswire/ -- DarwinHealth, Inc. today announced a scientific research collaboration employing itsBiomarker Enrichment Strategies for Trials (BEST platform) to elucidate novel biomarkers to guide translational trajectories for multiple oncology molecules being developed ...

2021-10-12 22:52 2099

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

* Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors * Investment serves customers in addressing larger patient populations with new curative treatments * Enables suspension production of viral vectors up to...

2021-10-12 21:00 2405

Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy

CBC-backed Jadeite Medicines Announces Exclusive Licensing Agreement with Albireo Pharma to Develop and Promote Odevixibat in Japan

TOKYO, Oct. 12, 2021 /PRNewswire/ -- Jadeite Medicines Inc. ("Jadeite"), a biopharmaceutical company that is backed bySingapore's CBC Group ("CBC") and committed to addressing critical unmet medical needs for patients inJapan, today entered into an exclusive licensing agreement with Albireo Pharm...

2021-10-12 20:30 1936

Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine

Agreement Expands on the Companies' Collaboration for the Preclinical Development of Potential Anti-Cancer Therapies TORRANCE, Calif., Oct. 12, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle ce...

2021-10-12 20:23 2027

Eleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins

FREIBURG, Germany, Oct. 12, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners. Its moss-based platform is ideally suited to produc...

2021-10-12 10:30 2102

Ascletis Announces Results of the Phase IIa trial of ASC22 (Envafolimab) in Patients with Chronic Hepatitis B to be Presented in Oral Parallel Session at The Liver Meeting(R) 2021 by American Association for the Study of Liver Diseases

HANGZHOU and SHAOXING, China, Oct. 12, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) announces today that the results of Phase IIa trial of subcutaneously administered PD-L1 antibody ASC22 (Envafolimab) in patients with chronic hepatitis B (CHB) will be presented in oral parallel session...

2021-10-12 08:30 2737

Sciwind Biosciences Completes $70 Million Series C Financing and Expands Leadership Team to Advance Metabolic Disease Pipeline

HANGZHOU, China and SAN FRANCISCO, Oct. 12, 2021 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the closing of an$70 million Series C financing. The f...

2021-10-12 08:00 3175

EVERSANA™ named a Great Place to Work for third consecutive year in U.S.; earns valuable recognition in Canada, China and India

CHICAGO, Oct. 11, 2021 /PRNewswire/ -- EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, is celebrating its designation as aGreat Place to Work® by the global authority in workplace culture. Based on an anonymous survey to more than 3,000 EVERSANA...

2021-10-11 23:22 2730

Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy

GUANGZHOU, China, Oct. 11, 2021 /PRNewswire/ -- The Twist Alliance Pan-Cancer Methylation Panel (Pan-Cancer Panel), a solution for pan-cancer study including DNA methylation library preparation and targeted enrichment for next-generation sequencing (NGS), was launched globally onSeptember 24th (U...

2021-10-11 21:00 2277

Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy

Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres® Y-90 resin microspheres in China

WOBURN, Mass., Oct. 11, 2021 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that the first procedure of selective internal radiation therapy (SIRT) using SIR-Spheres®Y-90 resin microspheres in China was successfully performed ...

2021-10-11 20:00 1604

CGM lab software modernizes healthcare in Timor-Leste

CGM SCHUYLAB improves patient care in low- and middle-income countries OWINGS MILLS, Md., Oct. 11, 2021 /PRNewswire/ -- A global leader in e-health technology, CompuGroup Medical (CGM) worked this summer with Timorese scientists andAustralia's Menzies School of Health Research to improve patient ...

2021-10-11 19:00 2312

CGM lab software modernizes healthcare in Timor-Leste

Sai Life Sciences presents mid-term report on Sai Nxt initiative; reveals upsurge in capabilities

- Completes two-thirds of its investment target of US$150M - Demonstrates a leap forward in capabilities across all focus areas – People, Processes, and Infrastructure HYDERABAD, India, Oct. 11, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development and Manufac...

2021-10-11 16:50 2407

Sai Life Sciences presents mid-term report on Sai Nxt initiative; reveals upsurge in capabilities

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA

GENEVA, Oct. 11, 2021 /PRNewswire/ -- 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAlliance's n...

2021-10-11 08:00 754

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA

Sequential Skin raise US $1.65M in oversubscribed seed round to revolutionise skin health with their novel skin microbiome testing kit

LONDON, Oct. 11, 2021 /PRNewswire/ -- Sequential Skin Ltd , a UK/Singapore biotech start-up has raised US $1.65M in its oversubscribed seed round – to revolutionise the future of skin health.

2021-10-11 06:00 2146

Sequential Skin raise US $1.65M in oversubscribed seed round to revolutionise skin health with their novel skin microbiome testing kit

AXA BetterMe Weekend concludes successfully

HONG KONG, Oct. 10, 2021 /PRNewswire/ -- In response to the World Mental Health Day and celebrating the 1st anniversary of AXA BetterMe, the holistic wellness platform on the Emma by AXA app, AXA Hong Kong andMacau ("AXA") hosted the "AXA BetterMe Weekend" (the "Event") on 7-10 October at Hysan P...

2021-10-10 17:54 3737

AXA BetterMe Weekend concludes successfully

Brii Bio Initiates Submission of Emergency Use Authorization Filing to U.S. FDA for BRII-196/BRII-198, its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients at High Risk of Clinical Progression to Severe Disease

DURHAM, N.C. and BEIJING, Oct. 9, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health...

2021-10-09 03:07 5150

VIRALEZE™ antiviral nasal spray launched in ADMENTA Italia Group pharmacies in Italy

MELBOURNE, Australia, Oct. 8, 2021 /PRNewswire/ -- Australian biotech company Starpharma today announced it has signed a sales and distribution agreement for its VIRALEZE™ antiviral nasal spray with ADMENTA Italia Group (ADMENTA), a leading pharmaceutical retail and wholesale distribution company...

2021-10-08 13:51 5016

Findings in New Book, Neurology in Migrants and Refugees, Presented at the World Congress of Neurology 2021, Raising Awareness on Neurological Issues Facing Migrants and Refugees

LONDON, Oct. 8, 2021 /PRNewswire/ -- Medical professionals around the world now have a new resource to help them understand the challenges of treating and caring for migrants and refugees with neurological problems, thanks to a new book authored by a Specialty Group of neurologists and neuroscien...

2021-10-08 12:12 1874

1 ... 203 204 205206207 208 209 ... 383